NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM602289 Query DataSets for GSM602289
Status Public on Dec 15, 2010
Title ESC_RNAseq
Sample type SRA
 
Source name Human embryonic stem cells
Organism Homo sapiens
Characteristics cell line: H9 ESC
Treatment protocol hESCs were differentiated into hNECs using a previously described differentiation protocol 21. Briefly, hESC were incubated with 2mg/ml collagenase. Once detached, cells were plated in NEC differentiation media: 1:1 Neurobasal medium/D-MEM F-12 medium (Invitrogen), 0.5x B-27 supplement minus Vitamin A (50x stock, Invitrogen), 0.5x N-2 supplement (100x stock, Invitrogen), 20 ng/ml bFGF (Peprotech), 20 ng/ml EGF (Sigma-Aldrich), 5 µg/ml bovine insulin (Sigma-Aldrich), 0.1 µg/ml recombinant human NOGGIN (Peprotech), 1x Glutamax-I supplement (100x stock, Invitrogen). Cells were differentiated for seven days, changing media every other day.
Growth protocol hESCs (H9 line, Wi-Cell) were expanded in feeder free, serum free medium, mTESR-1 from StemCell technologies. Cells were passaged 1:7 every 5-6 days by incubation with accutase (Invitrogen) long and resultant small cell clusters were subsequently re-plated on tissue culture dishes coated overnight with growth factor reduced matrigel (BD biosciences). hESCs quality was regularly tested by evaluating the expression of a panel of hESC markers (e.g. Alkaline phosphatase, OCT4) and the capacity to differentiate into cell types derived from the three germ layers.
Extracted molecule total RNA
Extraction protocol RNAs from hESC and NEC were extracted with Trizol (invitrogen), following manufacturer’s recommendations. 10 µg of total RNA were subjected to two rounds of oligo-dT purification using Dynal oligo (dT) beads (Invitrogen). 100 ng of the purified RNA were fragmented with 10x Fragmentation Buffer (Ambion). Fragmented RNA was used for first strand cDNA synthesis, using random hexamer primers (Invitrogen) and SuperScript II enzyme (Invitrogen). Second strand cDNA was obtained by adding RNAseH (Invitrogen) and DNA Pol I (New England Biolabs) to the first strand cDNA mix. The resulting double-stranded cDNA was used for Illumina library preparation according to Illumina's instructions accompanying the DNA Sample Kit (Part# 0801-0303). Briefly, DNA was end-repaired using a combination of T4 DNA polymerase, E. coli DNA Pol I large fragment (Klenow polymerase) and T4 polynucleotide kinase. The blunt, phosphorylated ends were treated with Klenow fragment (32 to 52 exo minus) and dATP to yield a protruding 3- 'A' base for ligation of Illumina's adapters which have a single 'T' base overhang at the 3’ end. After adapter ligation, DNA was size selected on agarose gel from 200-700 bp. Then isolated DNA was PCR amplified with Illumina primers for 18 cycles. The purified DNA was captured on an Illumina flow cell for cluster generation. Libraries were sequenced on the Genome Analyzer following the manufacturer's protocols.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina Genome Analyzer
 
Description polyA RNA
Data processing RNA-seq libraries were sequenced with Illumina Genome Analyzer and both mapping and analysis of resulting reads were perfomed with DNAnexus software tools (https://dnanexus.com)
 
Submission date Sep 29, 2010
Last update date May 15, 2019
Contact name Alvaro Rada
E-mail(s) alvaror@stanford.edu
Organization name Stanford University
Department Chemical and Systems Biology
Lab Wysocka lab
Street address 269 Campus Drive, CCSR Building
City Stanford
State/province CA
ZIP/Postal code 94305
Country USA
 
Platform ID GPL9052
Series (1)
GSE24447 A unique chromatin signature uncovers early developmental enhancers in humans
Relations
SRA SRX027480
BioSample SAMN00113788

Supplementary file Size Download File type/resource
GSM602289_ESC_RPKM.txt.gz 514.4 Kb (ftp)(http) TXT
SRA Run SelectorHelp
Processed data provided as supplementary file
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap